ES2169351T3 - Combinaciones que tienen efectos inmunosupresores, que contienen inhibidores de ciclooxigenasa-2 y 5-lipoxigenasa. - Google Patents
Combinaciones que tienen efectos inmunosupresores, que contienen inhibidores de ciclooxigenasa-2 y 5-lipoxigenasa.Info
- Publication number
- ES2169351T3 ES2169351T3 ES97904133T ES97904133T ES2169351T3 ES 2169351 T3 ES2169351 T3 ES 2169351T3 ES 97904133 T ES97904133 T ES 97904133T ES 97904133 T ES97904133 T ES 97904133T ES 2169351 T3 ES2169351 T3 ES 2169351T3
- Authority
- ES
- Spain
- Prior art keywords
- cycloxygenasa
- immunosuppressor
- combinations
- effects
- lipoxygenase inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000867 Lipoxygenase Inhibitor Substances 0.000 title abstract 2
- 239000003018 immunosuppressive agent Substances 0.000 title abstract 2
- 229940124125 5 Lipoxygenase inhibitor Drugs 0.000 abstract 1
- 229940093444 Cyclooxygenase 2 inhibitor Drugs 0.000 abstract 1
- 208000009329 Graft vs Host Disease Diseases 0.000 abstract 1
- 230000004913 activation Effects 0.000 abstract 1
- 230000001028 anti-proliverative effect Effects 0.000 abstract 1
- 230000001363 autoimmune Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003255 cyclooxygenase 2 inhibitor Substances 0.000 abstract 1
- 208000024908 graft versus host disease Diseases 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 229940124589 immunosuppressive drug Drugs 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 210000000265 leukocyte Anatomy 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 230000009257 reactivity Effects 0.000 abstract 1
- 230000004044 response Effects 0.000 abstract 1
- 238000002054 transplantation Methods 0.000 abstract 1
Classifications
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01M—PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
- H01M4/00—Electrodes
- H01M4/02—Electrodes composed of, or comprising, active material
- H01M4/24—Electrodes for alkaline accumulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01M—PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
- H01M4/00—Electrodes
- H01M4/02—Electrodes composed of, or comprising, active material
- H01M4/24—Electrodes for alkaline accumulators
- H01M4/26—Processes of manufacture
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01M—PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
- H01M4/00—Electrodes
- H01M4/02—Electrodes composed of, or comprising, active material
- H01M4/64—Carriers or collectors
- H01M4/70—Carriers or collectors characterised by shape or form
- H01M4/80—Porous plates, e.g. sintered carriers
- H01M4/808—Foamed, spongy materials
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01M—PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
- H01M50/00—Constructional details or processes of manufacture of the non-active parts of electrochemical cells other than fuel cells, e.g. hybrid cells
- H01M50/10—Primary casings; Jackets or wrappings
- H01M50/102—Primary casings; Jackets or wrappings characterised by their shape or physical structure
- H01M50/103—Primary casings; Jackets or wrappings characterised by their shape or physical structure prismatic or rectangular
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E60/00—Enabling technologies; Technologies with a potential or indirect contribution to GHG emissions mitigation
- Y02E60/10—Energy storage using batteries
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Electrochemistry (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Manufacturing & Machinery (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
SE DESCRIBE EL TRATAMIENTO CON UN INHIBIDOR DE CICLOOXIGENASA 2 Y UN INHIBIDOR DE 5 - LIPOXIGENASA COMO UTIL EN LA REDUCCION DEL RECHAZO INCIPIENTE DE ORGANOS TRANSPLANTADOS Y PARA EL TRATAMIENTO DE ENFERMEDADES AUTOINMUNITARIAS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60062296A | 1996-02-13 | 1996-02-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2169351T3 true ES2169351T3 (es) | 2002-07-01 |
Family
ID=24404352
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES97904133T Expired - Lifetime ES2169351T3 (es) | 1996-02-13 | 1997-02-12 | Combinaciones que tienen efectos inmunosupresores, que contienen inhibidores de ciclooxigenasa-2 y 5-lipoxigenasa. |
Country Status (11)
Country | Link |
---|---|
US (2) | US6376528B1 (es) |
EP (1) | EP0888127B1 (es) |
JP (1) | JP2000504723A (es) |
AT (1) | ATE210461T1 (es) |
AU (1) | AU1850597A (es) |
CA (1) | CA2246265A1 (es) |
DE (1) | DE69709069T2 (es) |
DK (1) | DK0888127T3 (es) |
ES (1) | ES2169351T3 (es) |
PT (1) | PT888127E (es) |
WO (1) | WO1997029776A1 (es) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6512121B2 (en) | 1998-09-14 | 2003-01-28 | G.D. Searle & Co. | Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
JP2000504723A (ja) | 1996-02-13 | 2000-04-18 | ジー.ディー.サール アンド カンパニー | シクロオキシゲナーゼ―2阻害剤および5―リポキシゲナーゼ阻害剤投与の免疫抑制効果 |
US6218437B1 (en) | 1996-09-30 | 2001-04-17 | The Regents Of The University Of California | Treatment and prevention of hepatic disorders |
AU1703799A (en) * | 1997-12-17 | 1999-07-05 | Cornell Research Foundation Inc. | Cyclooxygenase-2 inhibition |
US7041694B1 (en) * | 1997-12-17 | 2006-05-09 | Cornell Research Foundation, Inc. | Cyclooxygenase-2 inhibition |
US6194431B1 (en) | 1998-04-14 | 2001-02-27 | Paul D. Rubin | Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors |
JP2003504346A (ja) * | 1999-07-12 | 2003-02-04 | グランデイス・バイオテツク・ゲー・エム・ベー・ハー | 成長ホルモン製剤 |
US20030017148A1 (en) * | 2000-05-11 | 2003-01-23 | Oklahoma Medical Research Foundation | Prevention of insulin-dependent diabetes, complications thereof, or allograft rejection by inhibition of cyclooxygenase-2 activity |
US20020035107A1 (en) | 2000-06-20 | 2002-03-21 | Stefan Henke | Highly concentrated stable meloxicam solutions |
DE10121252A1 (de) * | 2001-04-30 | 2002-11-07 | Christos C Zouboulis | Behandlung der Akne |
AR038957A1 (es) | 2001-08-15 | 2005-02-02 | Pharmacia Corp | Terapia de combinacion para el tratamiento del cancer |
DE10161077A1 (de) | 2001-12-12 | 2003-06-18 | Boehringer Ingelheim Vetmed | Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion |
AU2003228789A1 (en) * | 2002-05-02 | 2003-12-02 | The Washington University | Methods and compositions for treating t cell mediated inflammatory/autoimmune diseases and disorders in subjects having a glucocorticoid regulation deficiency |
DE10223013A1 (de) * | 2002-05-22 | 2003-12-04 | Boehringer Ingelheim Int | Verwendung von Meloxicam für die Linderung von Organverletzungen während Organoperation oder -transplantation |
US8992980B2 (en) | 2002-10-25 | 2015-03-31 | Boehringer Ingelheim Vetmedica Gmbh | Water-soluble meloxicam granules |
AU2004237439B2 (en) | 2003-05-07 | 2009-09-10 | Osteologix A/S | Treating cartilage/bone conditions with water-soluble strontium salts |
DE10351035A1 (de) * | 2003-10-31 | 2005-05-25 | Merckle Gmbh Chemisch Pharmazeutische Fabrik | Pharmazeutische Licofelone-Formulierung |
US20050129764A1 (en) * | 2003-12-11 | 2005-06-16 | Vergez Juan A. | Osmotic device containing licofelone |
WO2005065681A1 (en) * | 2003-12-19 | 2005-07-21 | Takeda San Diego, Inc. | N- hydroxy-3-(3-(1h-imidazol-2-yl)-phenyl)-acrylamide derivatives and related compounds as histone deacetylase (hdac) inhibitors for the treatment of cancer |
WO2005079419A2 (en) * | 2004-02-17 | 2005-09-01 | The Regents Of The University Of California | Methods of treating immunopathological disorders |
EP1568369A1 (en) | 2004-02-23 | 2005-08-31 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the treatment of respiratory diseases in pigs |
WO2005123130A2 (en) * | 2004-06-17 | 2005-12-29 | Osteologix A/S | Improved treatments of rheumatic and arthritic diseases comprising combinations of a 5-lipoxygenase inhibitor |
DE102005012971A1 (de) * | 2005-03-21 | 2006-09-28 | Merckle Gmbh | Polymorphe Form von 6-(4-Chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-essigsäure |
KR101368988B1 (ko) | 2005-09-16 | 2014-02-28 | 다케다 야쿠힌 고교 가부시키가이샤 | 디펩티딜 펩티다제 억제제 |
TW200838536A (en) | 2006-11-29 | 2008-10-01 | Takeda Pharmaceutical | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
WO2009012425A2 (en) * | 2007-07-19 | 2009-01-22 | Logigal Therapeutics, Inc. | Compositions including leukotriene antagonists and nsaids and methods of using the same |
CN102413825A (zh) | 2009-04-29 | 2012-04-11 | 阿马里纳股份公司 | 含有epa和心血管剂的药物组合物以及使用其的方法 |
US9101529B2 (en) | 2009-10-12 | 2015-08-11 | Boehringer Ingelheim Vetmedica Gmbh | Containers for compositions comprising meloxicam |
US9149480B2 (en) | 2010-03-03 | 2015-10-06 | Boehringer Ingeleheim Vetmedica GmbH | Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats |
US9795568B2 (en) | 2010-05-05 | 2017-10-24 | Boehringer Ingelheim Vetmedica Gmbh | Low concentration meloxicam tablets |
MX2013009961A (es) * | 2011-03-01 | 2013-09-26 | Npharmakon Llc | Uso de n-(4-metoxifenil)-1-fenil-1h-pirazol-3-amina y compuestos relacionados. |
US10189830B2 (en) | 2013-03-15 | 2019-01-29 | Bioelectron Technology Corporation | Alkyl-heteroaryl substituted quinone derivatives for treatment of oxidative stress disorders |
WO2015077905A1 (en) * | 2013-11-29 | 2015-06-04 | Merck Sharp & Dohme Corp. | Bicycloamine-substituted-n-benzenesulfonamide compounds with selective activity in voltage-gated sodium channels |
EP3484464B1 (en) | 2016-03-22 | 2020-10-28 | Merck Sharp & Dohme Corp. | N1-phenylpropane-1,2-diamine compounds with selective activity in voltage-gated sodium channels |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59196839A (ja) | 1983-04-21 | 1984-11-08 | Sankyo Co Ltd | フエニル酢酸誘導体 |
US4686231A (en) * | 1985-12-12 | 1987-08-11 | Smithkline Beckman Corporation | Inhibition of 5-lipoxygenase products |
US4873259A (en) | 1987-06-10 | 1989-10-10 | Abbott Laboratories | Indole, benzofuran, benzothiophene containing lipoxygenase inhibiting compounds |
US5242940A (en) | 1987-05-29 | 1993-09-07 | Ortho Pharmaceutical Corporation | Pharmacologically active N-1 and C-5 heterocyclic pyrazoles and method for synthesizing the same |
DE3851152T2 (de) | 1987-09-03 | 1995-01-26 | Univ Georgia | Cyclosporin-augenmittel. |
US4889935A (en) * | 1987-12-18 | 1989-12-26 | American Home Products Corporation | Aminoguanidine derivatives |
GB8927287D0 (en) | 1988-12-23 | 1990-01-31 | Ici Plc | Cyclic ether derivatives |
US5234950A (en) | 1988-12-23 | 1993-08-10 | Imperial Chemical Industries Plc | Tetrahydrofuran derivatives |
US5220059A (en) | 1990-04-19 | 1993-06-15 | Abbott Laboratories | Lipoxygenase-inhibiting compounds derived from non-steroidal antiinflammatory carboxylic acids |
DK0540673T3 (da) | 1990-07-25 | 1997-03-24 | Abbott Lab | Acetylen-derivater med lipoxygenaseinhiberende virkning |
IE913655A1 (en) * | 1990-11-06 | 1992-05-22 | Zeneca Ltd | Synergistic agents |
JPH06505239A (ja) | 1991-01-31 | 1994-06-16 | ワーナー−ランバート・コンパニー | 抗炎症剤として有用な4,6−ジ−第三ブチル−5−ヒドロキシ−1,3−ピリミジンの置換されたヘテロアリール類似体 |
EP0532239B1 (en) * | 1991-09-10 | 1995-12-13 | Zeneca Limited | Benzenesulphonamide derivatives as 5-lipoxygenase inhibitors |
US5272178A (en) * | 1991-11-18 | 1993-12-21 | G. D. Searle & Co. | Compounds of cyclic phenolic thioethers which are useful in stimulating and inhibiting superoxide generation |
GB9215921D0 (en) | 1992-07-27 | 1992-09-09 | Wellcome Found | Anti-inflammatory compounds |
US5354865A (en) | 1992-09-10 | 1994-10-11 | Abbott Laboratories | Phenylmethyl derivatives having lipoxygenase inhibitory activity |
US5288751A (en) | 1992-11-06 | 1994-02-22 | Abbott Laboratories | [(Substituted) phenyalkyl]furylalkynyl-and [substituted) phenyalkyl] thienylalkynyl-N-hydroxyurea inhibitors or leukotriene biosynthesis |
US5604260A (en) | 1992-12-11 | 1997-02-18 | Merck Frosst Canada Inc. | 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2 |
JP3137648B2 (ja) | 1993-01-15 | 2001-02-26 | ジー.ディー.サール アンド カンパニー | 抗炎症剤としての用途を有する3,4−ジアリールチオフェンおよびその類似体 |
US5409944A (en) | 1993-03-12 | 1995-04-25 | Merck Frosst Canada, Inc. | Alkanesulfonamido-1-indanone derivatives as inhibitors of cyclooxygenase |
CA2161789A1 (en) | 1993-05-13 | 1994-11-24 | Jacques Yves Gauthier | 2-substituted-3,4-diarylthiophene derivatives as inhibitors of cyclooxygenase |
US5380738A (en) | 1993-05-21 | 1995-01-10 | Monsanto Company | 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents |
US5474995A (en) | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
US5298521A (en) | 1993-08-30 | 1994-03-29 | Ortho Pharmaceutical Corporation | 1,5-diphenyl-3-pyrazolylalkyl-N-hydroxydithiocaramates, compositions and use |
US5344991A (en) | 1993-10-29 | 1994-09-06 | G.D. Searle & Co. | 1,2 diarylcyclopentenyl compounds for the treatment of inflammation |
PT923933E (pt) | 1993-11-30 | 2002-10-31 | Searle & Co | Pirazolil-benzenossulfonamidas substituidas para usar no tratamento de inflamacao |
US5393790A (en) | 1994-02-10 | 1995-02-28 | G.D. Searle & Co. | Substituted spiro compounds for the treatment of inflammation |
US5486534A (en) * | 1994-07-21 | 1996-01-23 | G. D. Searle & Co. | 3,4-substituted pyrazoles for the treatment of inflammation |
RO119946B1 (ro) * | 1995-02-13 | 2005-06-30 | G.D. Searle & Co. | Derivaţi de izoxazol, utilizaţi pentru tratamentul inflamaţiilor |
US5643933A (en) | 1995-06-02 | 1997-07-01 | G. D. Searle & Co. | Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
AU5886296A (en) | 1995-06-02 | 1996-12-18 | G.D. Searle & Co. | Heterocyclo substituted hydroxamic acid derivatives as cyclo oxygenase-2 and 5-lipoxygenase inhibitors |
US5700816A (en) * | 1995-06-12 | 1997-12-23 | Isakson; Peter C. | Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor |
JPH11507670A (ja) * | 1995-06-12 | 1999-07-06 | ジー.ディー.サール アンド カンパニー | シクロオキシゲナーゼ−2インヒビターと5−リポキシゲナーゼインヒビターの組合せによる炎症と炎症関連疾患の治療 |
JP2000504723A (ja) | 1996-02-13 | 2000-04-18 | ジー.ディー.サール アンド カンパニー | シクロオキシゲナーゼ―2阻害剤および5―リポキシゲナーゼ阻害剤投与の免疫抑制効果 |
DE69715382T2 (de) * | 1996-02-13 | 2003-04-30 | G.D. Searle & Co., Chicago | Arzneimittelkombinationen mit immunosuppressiven wirkungen welche cyclooxygenase-2 inhibitoren und leukotrien lta4 hydrase-inhibitoren enthalten |
DE69733338T2 (de) | 1996-02-13 | 2006-03-16 | G.D. Searle & Co., Chicago | Zubereitungen, enthaltend einen cyclooxygenase-2-inhibitor und einen leukotrien-b4-rezeptor-antagonisten |
US5919776A (en) * | 1996-12-20 | 1999-07-06 | Merck & Co., Inc. | Substituted aminoquinolines as modulators of chemokine receptor activity |
US6013644A (en) * | 1997-12-12 | 2000-01-11 | Merck & Co., Inc. | Spiro-substituted azacycles as modulators of chemokine receptor activity |
WO2000076512A1 (en) * | 1999-06-11 | 2000-12-21 | Merck & Co., Inc. | Cyclopentyl modulators of chemokine receptor activity |
-
1997
- 1997-02-12 JP JP9529363A patent/JP2000504723A/ja not_active Ceased
- 1997-02-12 ES ES97904133T patent/ES2169351T3/es not_active Expired - Lifetime
- 1997-02-12 DK DK97904133T patent/DK0888127T3/da active
- 1997-02-12 AU AU18505/97A patent/AU1850597A/en not_active Abandoned
- 1997-02-12 EP EP97904133A patent/EP0888127B1/en not_active Expired - Lifetime
- 1997-02-12 WO PCT/US1997/001558 patent/WO1997029776A1/en active IP Right Grant
- 1997-02-12 AT AT97904133T patent/ATE210461T1/de not_active IP Right Cessation
- 1997-02-12 CA CA002246265A patent/CA2246265A1/en not_active Abandoned
- 1997-02-12 PT PT97904133T patent/PT888127E/pt unknown
- 1997-02-12 DE DE69709069T patent/DE69709069T2/de not_active Expired - Fee Related
-
1999
- 1999-10-18 US US09/430,072 patent/US6376528B1/en not_active Expired - Fee Related
-
2002
- 2002-03-15 US US10/098,644 patent/US7132441B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DK0888127T3 (da) | 2002-04-08 |
US6376528B1 (en) | 2002-04-23 |
AU1850597A (en) | 1997-09-02 |
ATE210461T1 (de) | 2001-12-15 |
DE69709069D1 (de) | 2002-01-24 |
EP0888127A1 (en) | 1999-01-07 |
US20020143033A1 (en) | 2002-10-03 |
US7132441B2 (en) | 2006-11-07 |
DE69709069T2 (de) | 2002-07-04 |
EP0888127B1 (en) | 2001-12-12 |
JP2000504723A (ja) | 2000-04-18 |
WO1997029776A1 (en) | 1997-08-21 |
CA2246265A1 (en) | 1997-08-21 |
PT888127E (pt) | 2002-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2169351T3 (es) | Combinaciones que tienen efectos inmunosupresores, que contienen inhibidores de ciclooxigenasa-2 y 5-lipoxigenasa. | |
PA8523901A1 (es) | Composiciones farmaceuticas de inhibidores de la proteina de transferencia de colesteril ester | |
TNSN00010A1 (fr) | DIPHENYLUREE A SUBSTITUTION ω CARBOXYARYLE SERVANT D'INHIBUTEURS DE RAF KINASE. | |
DK1032662T3 (da) | Fremgangsmåder og sammensætninger til immunmodulation | |
CY1109462T1 (el) | Συνθεση και διαδικασια εκχυλιση του διαλυτη μεταλλων χρησιμοποιωντας τους παραγοντες εκχυλισης αλδοξιμη ή κετοξιμη | |
DE69840025D1 (de) | Assoziierter antworten | |
YU49315B (sh) | Inhibitor protein kinaze c, njegove farmaceutske formulacije i postupak za dobijanje | |
ES2183140T3 (es) | Combinaciones, que tienen efectos inmunosupresores, que contienen un inhibidor de ciclooxigenasa-2 y un inhibidor de leucotrieno a4 hidrolasa. | |
ATE211553T1 (de) | Magazin zur bevorratung von testelementen | |
ATE388139T1 (de) | Pyridone als hemmer der sh2-domäne der src- familie | |
ATE350060T1 (de) | Mittel zur vorbeugung oder behandlung von pankreatitis die anti-il-6 receptor antikörper als aktive komponente enthalten | |
ES1053994U (es) | Elemento interior para cajones. | |
DE69601689D1 (de) | Informationsanzeigevorrichtung mit aufgerolltem bahnförmigem material | |
DE60127545D1 (de) | Verfahren zur deaktivierung von allergenen der hausstaubmilbe | |
ATE332919T1 (de) | Inhibitoren von phosphoserin- und phosphothreoninspezifischen isomerasen | |
FR2848116B1 (fr) | Composition cosmetique comprenant un inhibiteur des metallo-proteinases et un lipopeptide. | |
ES2170158T3 (es) | Composiciones topicas que contienen n-acetil-l-cisteina. | |
ATE414510T1 (de) | Verwendung von 13-hode als regulator der vaskulären biokompatibilität und als inhibitor der zellulären hyperplasie | |
DK0670677T3 (da) | Forstærker af Bacillus-pesticidaktivitet | |
TR199901703T2 (xx) | Siklooksijenaz-2 inhibit�rlerini anti-anjiyojenik ajanlar olarak kullanma y�ntemi. | |
EP2290077A3 (en) | Natural IGM antibodies and inhibitors thereof | |
TR200102448T2 (tr) | COPD tedavisi için kontrollu salma formülasyonu. | |
DK0636247T3 (da) | Fremgangsmåde og sammensætning til reduktion af virkningerne af endogen alkalisk phosphatase | |
PT906268E (pt) | Fluorenonas com substituicao alquiloxiamino e sua utilizacao como inibidores da proteina quinase c | |
WO2005044244A3 (de) | Verwendung von mrp4-inhibitoren zur behandlung und/oder prophylaxe kardiovaskulärer erkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 888127 Country of ref document: ES |